The Influence of Type 1 Diabetes Mellitus on Pulmonary Function and Exercise Capacity – Results from the Study of Health in Pomerania (SHIP)

Abstract

Background: Diabetes mellitus Type 1 (T1DM) is associated with metabolic and microvascular diseases as part of a multi-organ and multi-systemic disorder. The dense network of capillary vessels in the lungs may change during the course of the development of microangiopathy. The connective tissue as well as alveoli may be subjected to non-enzymatic glycosylation of proteins which may in turn affect pulmonary function. Previous studies investigating lung function in patients with type 1 diabetes have only been performed on small numbers of patients. Our study is based on population data of the Study of Health in Pomerania (SHIP).

Objective: To investigate the influence of metabolic control on pulmonary system function and to establish a decreased pulmonary system function as a late complication of T1DM in a population based setting.

Methods: The study is a case matched study with multiple controls based on participants with T1DM (SHIP-DM-1, n=73) and non-diabetics (SHIP-1, n=292) from the population based study of Pomerania. Data on lung function and exercise performance stratified by age, sex, body mass index and smoking habits in participants with T1DM and without diabetes were matched.

Results: Participants with T1DM showed a significantly lower total lung capacity, residual volume and forced vital capacity. The transfer factor for carbon monoxide, the maximum power output and oxygen uptake during exercise were significantly decreased in comparison to the general population without diabetes.

Conclusion: The pattern of abnormal pulmonary function as observed in the present study with a reduction in lung volume parameters and reduced oxygen uptake in participants with T1DM suggests a restrictive type of lung disease caused by an intrinsic lung tissue derangement as well as pulmonary microangiopathy.

Key words

diabetes mellitus type 1 - lung function - exercise capacity - population study

^* contributed equally to this work.

• References

• 1 Sandler M. Is the lung a ‘target organ’ in diabetes mellitus?. Archives of internal medicine 1990; 150: 1385-1388
• 2 Palmer AJ, Roze S, Valentine WJ et al. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Current medical research and opinion. 2004; 20 (Suppl. 01) S5-S26
• 3 Sternberg M, Cohen-Forterre L, Peyroux J. Connective tissue in diabetes mellitus: biochemical alterations of the intercellular matrix with special reference to proteoglycans, collagens and basement membranes. Diabete & metabolisme 1985; 11: 27-50
• 4 Bell D, Collier A, Matthews DM et al. Are reduced lung volumes in IDDM due to defect in connective tissue?. Diabetes 1988; 37: 829-831
• 5 Innocenti F, Fabbri A, Anichini R et al. Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus. Diabetes research and clinical practice 1994; 25: 161-168
• 6 Ljubic S, Metelko Z, Car N et al. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 1998; 114: 1033-1035
• 7 Verrotti A, Chiarelli F, Verini M et al. Pulmonary function in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 579-580
• 8 van Gent R, Brackel HJ, de Vroede M et al. Lung function abnormalities in children with type I diabetes. Respiratory medicine 2002; 96: 976-978
• 9 Ramirez LC, Dal Nogare A, Hsia C et al. Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus. The American journal of medicine 1991; 91: 371-376
• 10 Williams PT. Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Medicine and science in sports and exercise 2001; 33: 754-761
• 11 Baldi JC, Cassuto NA, Foxx-Lupo WT et al. Glycemic status affects cardiopulmonary exercise response in athletes with type I diabetes. Medicine and science in sports and exercise 2010; 42: 1454-1459
• 12 Komatsu WR, Gabbay MA, Castro ML et al. Aerobic exercise capacity in normal adolescents and those with type 1 diabetes mellitus. Pediatric diabetes 2005; 6: 145-149
• 13 Wanke T, Formanek D, Auinger M et al. Pulmonary gas exchange and oxygen uptake during exercise in patients with type 1 diabetes mellitus. Diabetic medicine: a journal of the British Diabetic Association 1992; 9: 252-257
• 14 Volzke H, Alte D, Schmidt CO et al. Cohort profile: the study of health in Pomerania. International journal of epidemiology 2011; 40: 294-307
• 15 WHO . e. WHO Collaborating Centre for Drug Statistics Methodology. WHO; Geneva: 2005
• 16 Standardization of spirometry–1987 update . Statement of the American Thoracic Society. The American review of respiratory disease 1987; 136: 1285-1298
• 17 Nelson SB, Gardner RM, Crapo RO et al. Performance evaluation of contemporary spirometers. Chest 1990; 97: 288-297
• 18 Wanger J, Clausen JL, Coates A et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-522
• 19 Quanjer PH, Tammeling GJ, Cotes JE et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. The European respiratory journal Supplement. 1993; 16: 5-40
• 20 American Thoracic Society/European Respiratory S . ATS/ERS Statement on respiratory muscle testing. American journal of respiratory and critical care medicine 2002; 166: 518-624
• 21 Koch B, Schaper C, Ittermann T et al. Reference values for respiratory pressures in a general adult population – results of the Study of Health in Pomerania (SHIP). Clinical physiology and functional imaging 2010; 30: 460-465
• 22 Jones NL, Makrides L, Hitchcock C et al. Normal standards for an incremental progressive cycle ergometer test. The American review of respiratory disease 1985; 131: 700-708
• 23 American Thoracic S, American College of Chest P . ATS/ACCP Statement on cardiopulmonary exercise testing. American journal of respiratory and critical care medicine 15 2003; 167: 211-277
• 24 Force ERST, Palange P, Ward SA et al. Recommendations on the use of exercise testing in clinical practice. The European respiratory journal 2007; 29: 185-209
• 25 Wasserman KHJSD, Stringer WW, Whipp BJ. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. Vol. 4^th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2004
• 26 R K. Quantile Regression 2005
• 27 Lange P, Groth S, Kastrup J et al. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. The European respiratory journal 1989; 2: 14-19
• 28 Schuyler MR, Niewoehner DE, Inkley SR et al. Abnormal lung elasticity in juvenile diabetes mellitus. The American review of respiratory disease 1976; 113: 37-41
• 29 Primhak RA, Whincup G, Tsanakas JN et al. Reduced vital capacity in insulin-dependent diabetes. Diabetes 1987; 36: 324-326
• 30 Schnapf BM, Banks RA, Silverstein JH et al. Pulmonary function in insulin-dependent diabetes mellitus with limited joint mobility. The American review of respiratory disease 1984; 130: 930-932
• 31 Sandler M, Bunn AE, Stewart RI. Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. The American review of respiratory disease 1987; 135: 223-229
• 32 Brownlee M, Cerami A, Vlassara H. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes/metabolism reviews 1988; 4: 437-451
• 33 Fuso L, Cotroneo P, Basso S et al. Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus. Chest 1996; 110: 1009-1013
• 34 Fuso L, Paladini L, Pitocco D et al. Pulmonary diffusing capacity for carbon monoxide: a marker of depressed hypercapnic drive in type 1 diabetes mellitus?. Diabetic medicine: a journal of the British Diabetic Association 2011; 28: 1407-1411
• 35 Sandler M, Bunn AE, Stewart RI. Pulmonary function in young insulin-dependent diabetic subjects. Chest 1986; 90: 670-675
• 36 Popov D, Hasu M, Costache G et al. Capillary and aortic endothelia interact in situ with nonenzymatically glycated albumin and develop specific alterations in early experimental diabetes. Acta diabetologica 1997; 34: 285-293
• 37 Weir DC, Jennings PE, Hendy MS et al. Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy. Thorax 1988; 43: 725-726
• 38 Villa MP, Montesano M, Barreto M et al. Diffusing capacity for carbon monoxide in children with type 1 diabetes. Diabetologia 2004; 47: 1931-1935
• 39 Komatsu WR, Barros Neto TL, Chacra AR et al. Aerobic exercise capacity and pulmonary function in athletes with and without type 1 diabetes. Diabetes care 2010; 33: 2555-2557
• 40 Baraldi E, Monciotti C, Filippone M et al. Gas exchange during exercise in diabetic children. Pediatric pulmonology 1992; 13: 155-160
• 41 Gusso S, Hofman P, Lalande S et al. Impaired stroke volume and aerobic capacity in female adolescents with type 1 and type 2 diabetes mellitus. Diabetologia 2008; 51: 1317-1320
• 42 Baldi JC, Hofman PL. Does careful glycemic control improve aerobic capacity in subjects with type 1 diabetes?. Exercise and sport sciences reviews 2010; 38: 161-167
• 43 Veves A, Saouaf R, Donaghue VM et al. Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes 1997; 46: 1846-1852
• 44 Hoo AF, Stocks J, Lum S et al. Development of lung function in early life: influence of birth weight in infants of nonsmokers. American journal of respiratory and critical care medicine 2004; 170: 527-533
• 45 Garcia Cuartero B, Gonzalez Vergaz A, Herranz S et al. Low birth weight is a risk factor for type 1 diabetes. Anales de pediatria 2009; 70: 542-546